• Avalon GloboCare to develop intranasal and oral Covid-19 vaccine pharmaceutical-technology
    June 28, 2020
    US-based biotech firm Avalon GloboCare has collaborated with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine against Covid-19 for intranasal or oral administration.
PharmaSources Customer Service